UCB announces MHRA approval for UCB’s Zilbrysq
18th January 2024 Uncategorised 0Green light concerns generalised myasthenia gravis therapy
More: UCB announces MHRA approval for UCB’s Zilbrysq
Source: News
Green light concerns generalised myasthenia gravis therapy
More: UCB announces MHRA approval for UCB’s Zilbrysq
Source: News
© 1994 - 2026 B.M. Pharmaceuticals